PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)
Pfizer and BioNTech Initiate COVID-19 Vaccine Trial in Children Under 12
Published: Mar 26, 2021 | Tags: Pfizer and BioNTech, Initiate, COVID-19 Vaccine Trial, Children, Under 12
Published: Mar 26, 2021 | Tags: Tetra Bio-Pharma, Initiates, Additional Studies, ARDS-003, Neuroinflammation, Antiviral Diseases
Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities
Published: Mar 26, 2021 | Tags: Immunai, Acquire, Dropprint Genomics, Expand, Target, Discovery Capabilities
Published: Mar 26, 2021 | Tags: Astellas and Seagen, Report, EMA, Acceptance, MAA, Enfortumab Vedotin, Treat, Locally, Advanced, Metastatic, Urothelial Cancer
Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue
Published: Mar 26, 2021 | Tags: Takeda, Reports, EMA, Acceptance, TAK-003, Prevention, Dengue
Published: Mar 26, 2021 | Tags: BMS, Report, Results, Relatlimab, Opdivo (nivolumab), P-II/III RELATIVITY-047 Study, Patients, Previously, Untreated, Metastatic, Unresectable Melanoma
Pfizer and Myovant Report Results of Relugolix Combination Therapy in P-III LIBERTY Withdrawal Study in Women with Uterine Fibroids
Published: Mar 25, 2021 | Tags: Pfizer and Myovant, Report, Results, Relugolix Combination Therapy, P-III LIBERTY, Withdrawal Study, Women, Uterine Fibroids
ProQR Reports Results of QR-421 in P-I/II Stellar Trial for Usher Syndrome
Published: Mar 25, 2021 | Tags: ProQR, Reports, Results, QR-421, P-I/II Stellar Trial, Usher Syndrome
Published: Mar 25, 2021 | Tags: EirGenix, Report, Results, EG12014 (biosimilar, trastuzumab), P-III Trial, HER2-Positive Breast Cancer
J&J Visions' Acuvue Theravision with Ketotifen Receives MHLW's Approval for Vision Correction and Allergic Eye Itch
Published: Mar 25, 2021 | Tags: J&J Visions, Acuvue Theravision, Ketotifen, Receives, MHLW, Approval, Vision Correction, Allergic Eye Itch
Chugai's Polivy Receives MHLW's Approval for Relapsed or Refractory Diffuse Large B-cell Lymphoma
Published: Mar 25, 2021 | Tags: Chugai, Polivy, Receives, MHLW, Approval, Relapsed, Refractory Diffuse Large B-cell Lymphoma
Published: Mar 25, 2021 | Tags: AstraZeneca, Reports, Results, AZD1222, Primary Analysis, P-III Trial, Prevention, COVID-19
Published: Mar 24, 2021 | Tags: Bayer, Vitrakvi, Receives, MHLW, Approval, Treatment, NTRK Fusion-Positive, Advanced, Recurrent, Solid Tumors
Novo Nordisk Presents Results of Semaglutide in P-IIIa STEP 4 Trial to Treat Obesity at ENDO 2021
Published: Mar 24, 2021 | Tags: Novo Nordisk, Presents, Results, Semaglutide, P-IIIa STEP 4 Trial, Treat, Obesity
Published: Mar 24, 2021 | Tags: Fresenius Medical Care, Collaborates, DaVita, Expand, Use, NxStage Home Hemodialysis Machines
Published: Mar 24, 2021 | Tags: Incyte, Pemazyre (pemigatinib), Receives, MHLW, Approval, Unresectable, Biliary Tract Cancer, FGFR2 Fusion Gene
Published: Mar 24, 2021 | Tags: Zealand, Zegalogue (dasiglucagon), Receives, US, FDA, Approval, Treatment, Severe, Hypoglycemia
Roche Launches New Configurations for Cobas Pro to Increase Testing Efficiency
Published: Mar 24, 2021 | Tags: Roche, Launches, New Configurations, Cobas Pro, Increase, Testing, Efficiency
Regeneron Reports Results of REGEN-COV Antibody Cocktail in P-III Trial to Prevent COVID-19
Published: Mar 23, 2021 | Tags: Regeneron, Reports, Results, REGEN-COV Antibody Cocktail, P-III Trial, Prevent, COVID-19
Novo Nordisk Receives the US FDA's Refusal to File Letter for Semaglutide to Treat T2D
Published: Mar 23, 2021 | Tags: Novo Nordisk, Receives, US, FDA, Refusal, File Letter, Semaglutide, Treat, T2D
Insulet Presents Results of Omnipod 5 Automated Insulin Delivery System for T1D at ENDO 2021
Published: Mar 23, 2021 | Tags: Insulet, Presents, Results, Omnipod 5 Automated Insulin Delivery System, T1D
Roche Pauses Dosing of Tominersen in P-III GENERATION HD1 for Manifest Huntington's Disease
Published: Mar 23, 2021 | Tags: Roche, Pauses, Dosing, Tominersen, P-III GENERATION HD1, Manifest Huntington's Disease
Roche Reports Results of Tecentriq in P-III IMpower010 Study for Patients with Early Lung Cancer
Published: Mar 23, 2021 | Tags: Roche, Reports, Results, Tecentriq, P-III IMpower010 Study, Patients, Early, Lung Cancer
Takeda Collaborates with Evotec on RNA Targeting Drug Development
Published: Mar 23, 2021 | Tags: Takeda, Collaborates, Evotec, RNA Targeting, Drug Development
AstraZeneca's AZD1222 Meets its Primary Endpoint in Preventing COVID-19
Published: Mar 22, 2021 | Tags: AstraZeneca, AZD1222, Meets, Primary Endpoint, Preventing, COVID-19
Published: Mar 22, 2021 | Tags: BioMarin, Report, Results, Vosoritide, P-III OLE Study, Treatment, Children, Achondroplasia
BridgeBio Presents Results of Encaleret in P-IIb Study for the Treatment of ADH1 at ENDO 2021
Published: Mar 22, 2021 | Tags: BridgeBio, Presents, Results, Encaleret, P-IIb Study, Treatment, ADH1
Published: Mar 22, 2021 | Tags: Janssen, Ponvory (ponesimod), Receives, US, FDA, Approval, Treatment, Relapsing, Multiple Sclerosis
Published: Mar 22, 2021 | Tags: Merck, Presents, Results, Keytruda (pembrolizumab), Lenvima (lenvatinib), P-III KEYNOTE-775/Study 309 trial, Treatment, Advanced, Endometrial Cancer
Published: Mar 22, 2021 | Tags: BMS, Reports, US, FDA, Acceptance, NDA, Mavacamten, Treat, Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Related Post: PharmaShots Weekly Snapshots (Mar 15 - 19, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com